Results 151 to 160 of about 30,735 (203)

Clinical utility of the ESTRO-EORTC classification in oligometastatic disease treated with stereotactic body radiotherapy: a single-institution retrospective study. [PDF]

Clin Exp Metastasis
Goto M, Nonaka T, Maruyama D, Ishii G, Nakamura M, Baba K, Nitta H, Sakurai H.   +7 more
europepmc   +1 more source

Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer. [PDF]

ESMO Open
Lee JB, Kim KH, Yoon S, Song SY, Lee SS, Jo S, Ahn HK, Kim HJ, Choi SJ, Park H, Hong MH, Cho BC, Yoon HI, Lim SM.   +13 more
europepmc   +1 more source

Stereotactic body radiotherapy in early-stage hepatocellular carcinoma: a systematic review and meta-analysis. [PDF]

ESMO Gastrointest Oncol
van Vulpen JK, Verwijs MC, Gommers FK, van Eijck van Heslinga RAH, van Meer S, Verstraete CJR, Hagendoorn J, Lam MGEH, Haj Mohammad N, Smits MLJ, Braat MNGJA, Intven MPW, de Bruijne J.   +12 more
europepmc   +1 more source

Comparative Performance of Stereotactic Body Radiotherapy and Lenvatinib in Unresectable Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis: A Propensity Score-Matched Cohort Analysis. [PDF]

J Hepatocell Carcinoma
Huang J, Liu FC, Yang Y, Yuan SX, Gu FM, Jiang BG, Pan ZY.   +6 more
europepmc   +1 more source

A Case Report of Preoperative Stereotactic Body Radiotherapy as Part of Multimodal Treatment in Pediatric Extraskeletal Ewing Sarcoma: An Innovative Treatment Strategy. [PDF]

Cureus
Mohammadipour S, Gultekin M, Susam Sen H, Ardicli B, Gedikoglu MG, Orhan D, Oguz B, Bozkurt MF, Varan A, Yildiz F.   +9 more
europepmc   +1 more source

A retrospective comparative evaluation of rectal preparation strategies for patients undergoing stereotactic body radiotherapy for prostate cancer. [PDF]

Br J Radiol
Tran MN, Didiodato G, Lamb A, Quinn P, Kim J, Conway J, Stevens C, Yoon F, McLean J, Gladwish A.   +9 more
europepmc   +1 more source

The role of stereotactic body radiotherapy in the management of hepatocellular carcinoma with macroscopic vascular invasion: a narrative review. [PDF]

ESMO Gastrointest Oncol
Gerard IJ, Glynn AM, Faye MD, Yan M, Mesci A, Kim TK, Vanner R, Dawson LA.   +7 more
europepmc   +1 more source

Reirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapy. [PDF]

J Appl Clin Med Phys
Grimm J, Mahadevan A, Obayomi-Davies O, Soltys SG, Sahgal A, Redmond KJ, Milano MT, Tomé WA, Brooks K, Dodd S, Vargo JA, Subedi G, Xue J, Ebid B, Ehret F, Rhieu BA, Fürweger C, Grimm R, Muacevic A, Moiseenko V, Kalnicki S, McLaughlin M, Kleinberg LR, Adler JR, Gibbs IC.   +24 more
europepmc   +1 more source

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial. [PDF]

Clin Transl Radiat Oncol
Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM.   +20 more
europepmc   +1 more source

A practical non-custom abdominal corset-based approach for diaphragm motion management in stereotactic body radiotherapy. [PDF]

Radiat Oncol
Kirli Bolukbas M, Bagci Kilic M, Soydemir GP, Figen M, Topalak B, Kocak Uzel E.   +5 more
europepmc   +1 more source